Sandrine Opi

1.4k citations

28 papers · 1.1k indexed · h-index 18

Co-authors: Eri Miyagi Sandra Kao Klaus Strebel Ritu Goila-Gaur Hiroaki Takeuchi Mohammad A. Khan Erwann Loret Didier Esquieu
Topics: HIV Research and Treatment (21 papers)HIV/AIDS drug development and treatment (14 papers)Immune Cell Function and Interaction (6 papers)
Cited by: Virology Infectious Diseases Immunology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Molecular and Cellular Biology
Partner nations: France United States China

In The Last Decade

Sandrine Opi

28 papers receiving 1.1k citations

Peers

Countries citing papers authored by Sandrine Opi

Since Specialization

Citations

This map shows the geographic impact of Sandrine Opi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandrine Opi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandrine Opi more than expected).

Fields of papers citing papers by Sandrine Opi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandrine Opi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandrine Opi. The network helps show where Sandrine Opi may publish in the future.

Co-authorship network of co-authors of Sandrine Opi

This figure shows the co-authorship network connecting the top 25 collaborators of Sandrine Opi. A scholar is included among the top collaborators of Sandrine Opi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandrine Opi. Sandrine Opi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structural recognition mechanisms between human Src homology domain 3 (SH3) and ALG‐2‐interacting protein X (Alix) 2012 ·FEBS Letters ·Xiaoli Shi,S. Betzi,Adrien Lugari,Sandrine Opi,Audrey Restouin,Isabelle Parrot,Jean Martínez,Pascale Zimmermann,Patrick Lécine,Mingdong Huang,Stefan T. Arold,Yves Collette,Xavier Morelli	6
2	A specific protein disorder catalyzer of HIV-1 Nef 2011 ·Bioorganic & Medicinal Chemistry ·Adrien Lugari,Sebastian Breuer,Thibault Coursindel,Sandrine Opi,Audrey Restouin,Xiaoli Shi,Alexis Nazabal,Bruce E. Torbett,Jean Martínez,Yves Collette,Isabelle Parrot,Stefan T. Arold,Xavier Morelli	4
3	Identification and biophysical assessment of the molecular recognition mechanisms between the human haemopoietic cell kinase Src homology domain 3 and ALG-2-interacting protein X 2010 ·Biochemical Journal ·Xiaoli Shi,Sandrine Opi,Adrien Lugari,Audrey Restouin,Thibault Coursindel,Isabelle Parrot,Javier Pérez,Éric Madore,Pascale Zimmermann,Jacques Corbeil,Mingdong Huang,Stefan T. Arold,Yves Collette,Xavier Morelli	9
4	Alternative Splicing Modulates Autoinhibition and SH3 Accessibility in the Src Kinase Fyn 2009 ·Molecular and Cellular Biology ·(unknown),Maria Paola Paronetto,Sandrine Opi,(unknown),Stéphane Audebert,Vincent Feuillet,Georges Bismuth,Serge Roche,Stefan T. Arold,Claudio Sette,Yves Collette	28
5	Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif 2007 ·Virology ·Sandra Kao,Ritu Goila-Gaur,Eri Miyagi,Mohammad A. Khan,Sandrine Opi,Hiroaki Takeuchi,Klaus Strebel	31
6	Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions 2007 ·Retrovirology ·Mohammad A. Khan,Ritu Goila-Gaur,Sandrine Opi,Eri Miyagi,Hiroaki Takeuchi,Sandra Kao,Klaus Strebel	66
7	Tat mutations in an African cohort that do not prevent transactivation but change its immunogenic properties 2007 ·Vaccine ·Grant R. Campbell,(unknown),Jennifer Watkins,Didier Esquieu,Sandrine Opi,David Yirrell,Pontiano Kaleebu,Erwann Loret	11
8	HIV-1 Vif promotes the formation of high molecular mass APOBEC3G complexes 2007 ·Virology ·Ritu Goila-Gaur,Mohammad A. Khan,Eri Miyagi,Sandra Kao,Sandrine Opi,Hiroaki Takeuchi,Klaus Strebel	38
9	Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1 2007 ·Journal of Virology ·Eri Miyagi,Sandrine Opi,Hiroaki Takeuchi,(unknown),Ritu Goila-Gaur,Sandra Kao,Klaus Strebel	129
10	Protein–protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein 2007 ·Proceedings of the National Academy of Sciences ·S. Betzi,Audrey Restouin,Sandrine Opi,Stefan T. Arold,Isabelle Parrot,Françoise Guerlesquin,Xavier Morelli,Yves Collette	85
11	Reservoir cells no longer detectable after a heterologous SHIV challenge with the synthetic HIV-1 Tat Oyi vaccine 2006 ·Retrovirology ·Jennifer Watkins,Sophie Lancelot,Grant R. Campbell,Didier Esquieu,(unknown),Sandrine Opi,(unknown),Jean‐Pierre Salles,Erwann Loret	22
12	HIV-1 Tat protein enhances Microtubule polymerization 2005 ·Retrovirology ·(unknown),Manon Carré,Pascale Barbier,Grant R. Campbell,Sophie Lancelot,Sandrine Opi,Didier Esquieu,Jennifer Watkins,C Prévôt,Diane Braguer,Vincent Peyrot,Erwann Loret	48
13	Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells 2004 ·Retrovirology ·Sandra Kao,Eri Miyagi,Mohammad A. Khan,Hiroaki Takeuchi,Sandrine Opi,Ritu Goila-Gaur,Klaus Strebel	86
14	Full-length HIV-1 Tat protein necessary for a vaccine 2004 ·Vaccine ·Sandrine Opi,Jean‐Marie Péloponèse,Didier Esquieu,Jennifer Watkins,Grant R. Campbell,(unknown),Kuan-Teh Jeang,David Yirrell,Pontiano Kaleebu,Erwann Loret	22
15	A possible improvement for structure-based drug design illustrated by the discovery of a Tat HIV-1 inhibitor 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Giang Vo‐Thanh,(unknown),Valérie Fargeas,(unknown),(unknown),Didier Dubreuil,Didier Esquieu,Catherine Grégoire,Sandrine Opi,Jean‐Marie Péloponèse,Grant R. Campbell,Jennifer Watkins,(unknown),Anné-Marie Aubertin,Christian Bailly,Erwann Loret,Jacques Lebreton	10
16	Discovery of a Tat HIV‐1 Inhibitor through Computer‐Aided Drug Design 2003 ·Journal of Spectroscopy ·Didier Esquieu,Jean‐Marie Péloponèse,Sandrine Opi,Catherine Grégoire,(unknown),Jennifer Watkins,Grant R. Campbell,(unknown),James N. Sturgis,Myriam Witvrouw,Christophe Pannecouque,Erik De Clercq,(unknown),Giang Vo‐Thanh,(unknown),Valérie Fargeas,Jacques Lebreton,Erwann Loret	6
17	Tat HIV-1 Primary and Tertiary Structures Critical to Immune Response Against Non-homologous Variants 2002 ·Journal of Biological Chemistry ·Sandrine Opi,Jean‐Marie Péloponèse,Didier Esquieu,Grant R. Campbell,(unknown),Anne Walburger,(unknown),Catherine Grégoire,Emmanuelle Bouveret,David Yirrell,Erwann Loret	34
18	Evolution of maurotoxin conformation and blocking efficacy towards Shaker B channels during the course of folding and oxidation in vitro 2002 ·Biochemical Journal ·Eric di Luccio,Alessandra Matavel,Sandrine Opi,Imed Regaya,Guillaume Sandoz,Sarrah Ben M’Barek,Edmond Carlier,É. Estève,(unknown),Ziad Fajloun,Hervé Rochat,Erwann Loret,Michel De Waard,Jean‐Marc Sabatier	6
19	Homonuclear ¹H‐NMR assignment and structural characterization of human immunodeficiency virus type 1 Tat Mal protein 2001 ·Biopolymers ·Catherine Grégoire,Jean‐Marie Péloponèse,Didier Esquieu,Sandrine Opi,Grant R. Campbell,(unknown),Évelyne Lebrun,Jacques Lebreton,Erwann Loret	42
20	1H-13C nuclear magnetic resonance assignment and structural characterization of HIV-1 Tat protein 2000 ·Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie ·Jean‐Marie Péloponèse,Catherine Grégoire,Sandrine Opi,Didier Esquieu,James N. Sturgis,Évelyne Lebrun,Éliane Meurs,Yves Collette,Daniel Olive,Anné-Marie Aubertin,(unknown),Christophe Pannecouque,Erik De Clercq,Christian Bailly,Jacques Lebreton,Erwann Loret	63

About Sandrine Opi

Sandrine Opi is a scholar working on Virology, Infectious Diseases and Immunology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (21 papers), HIV/AIDS drug development and treatment (14 papers) and Immune Cell Function and Interaction (6 papers). The work is most often cited by research in Virology (857 citations), Infectious Diseases (469 citations) and Immunology (299 citations). Sandrine Opi has collaborated with scholars based in France, United States and China. Frequent co-authors include Eri Miyagi, Sandra Kao, Klaus Strebel, Ritu Goila-Gaur, Hiroaki Takeuchi, Mohammad A. Khan, Erwann Loret, Didier Esquieu, Grant R. Campbell and Yves Collette. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact